• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌EMT相关lncRNA预后特征的鉴定与验证

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.

作者信息

Li Danfeng, Lin Xiaosheng, Chen Binlie, Ma Zhiyan, Zeng Yongming, Wang Huaiming

机构信息

Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Medical College, Shantou University, Shantou, China.

出版信息

Front Genet. 2021 Sep 22;12:723802. doi: 10.3389/fgene.2021.723802. eCollection 2021.

DOI:10.3389/fgene.2021.723802
PMID:34659346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8513715/
Abstract

This study aimed to explore the biological functions and prognostic role of Epithelial-mesenchymal transition (Epithelial-mesenchymal transition)-related lncRNAs in colorectal cancer (CRC). The Cancer Genome Atlas database was applied to retrieve gene expression data and clinical information. An EMT-related lncRNA risk signature was constructed relying on univariate Cox regression, Least Absolute Shrinkage and Selector Operation (LASSO) and multivariate Cox regression analysis of the EMT-related lncRNA expression data and clinical information. Then, an individualized prognostic prediction model based on the nomogram was developed and the predictive accuracy and discriminative ability of the nomogram were determined by the receiver operating characteristic curve and calibration curve. Finally, a series of analyses, such as functional analysis and unsupervised cluster analysis, were conducted to explore the influence of independent lncRNAs on CRC. A total of 581 patients were enrolled and an eleven-EMT-related lncRNA risk signature was identified relying on the comprehensive analysis of the EMT-related lncRNA expression data and clinical information in the training cohort. Then, risk scores were calculated to divide patients into high and low-risk groups, and the Kaplan-Meier curve analysis showed that low-risk patients tended to have better overall survival (OS). Multivariate Cox regression analysis indicated that the EMT-related lncRNA signature was significantly associated with prognosis. The results were subsequently confirmed in the validation dataset. Then, we constructed and validated a predictive nomogram for overall survival based on the clinical factors and risk signature. Functional characterization confirmed this signature could predict immune-related phenotype and was associated with immune cell infiltration (i.e., macrophages M0, M1, Tregs, CD4 memory resting cells, and neutrophils), tumor mutation burden (TMB). Our study highlighted the value of the 11-EMT-lncRNA signature as a predictor of prognosis and immunotherapeutic response in CRC.

摘要

本研究旨在探讨上皮-间质转化(Epithelial-mesenchymal transition,EMT)相关长链非编码RNA(lncRNAs)在结直肠癌(CRC)中的生物学功能及预后作用。应用癌症基因组图谱数据库检索基因表达数据和临床信息。基于EMT相关lncRNA表达数据和临床信息,通过单因素Cox回归、最小绝对收缩和选择算子(LASSO)以及多因素Cox回归分析构建EMT相关lncRNA风险特征。然后,开发基于列线图的个体化预后预测模型,并通过受试者工作特征曲线和校准曲线确定列线图的预测准确性和鉴别能力。最后,进行一系列分析,如功能分析和无监督聚类分析,以探讨独立lncRNAs对CRC的影响。共纳入581例患者,通过对训练队列中EMT相关lncRNA表达数据和临床信息的综合分析,确定了一个包含11个与EMT相关的lncRNA风险特征。然后,计算风险评分将患者分为高风险和低风险组,Kaplan-Meier曲线分析表明低风险患者总体生存率(OS)往往更好。多因素Cox回归分析表明,EMT相关lncRNA特征与预后显著相关。随后在验证数据集中证实了该结果。然后,我们基于临床因素和风险特征构建并验证了总体生存的预测列线图。功能特征证实该特征可预测免疫相关表型,并与免疫细胞浸润(即巨噬细胞M0、M1、调节性T细胞、CD4记忆静止细胞和中性粒细胞)、肿瘤突变负荷(TMB)相关。我们的研究强调了11个EMT-lncRNA特征作为CRC预后和免疫治疗反应预测指标的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/2367ff55aebf/fgene-12-723802-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/b0fda359aaac/fgene-12-723802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/c0acfa9eba0e/fgene-12-723802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/ba2d44ff584b/fgene-12-723802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/3745f460058e/fgene-12-723802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/89391299dd95/fgene-12-723802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/fc911e337a01/fgene-12-723802-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/2f66e5cb0660/fgene-12-723802-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/2367ff55aebf/fgene-12-723802-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/b0fda359aaac/fgene-12-723802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/c0acfa9eba0e/fgene-12-723802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/ba2d44ff584b/fgene-12-723802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/3745f460058e/fgene-12-723802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/89391299dd95/fgene-12-723802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/fc911e337a01/fgene-12-723802-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/2f66e5cb0660/fgene-12-723802-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8236/8513715/2367ff55aebf/fgene-12-723802-g008.jpg

相似文献

1
Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.结直肠癌EMT相关lncRNA预后特征的鉴定与验证
Front Genet. 2021 Sep 22;12:723802. doi: 10.3389/fgene.2021.723802. eCollection 2021.
2
Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.鉴定 EMT 相关 lncRNA 特征预测子宫内膜癌患者的预后。
Comb Chem High Throughput Screen. 2023;26(8):1488-1502. doi: 10.2174/1386207325666221005122554.
3
Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.在透明细胞肾细胞癌中鉴定与上皮-间质转化相关的lncRNA及其预后和分子亚型
Front Oncol. 2020 Nov 25;10:591254. doi: 10.3389/fonc.2020.591254. eCollection 2020.
4
Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.探讨乳腺癌上皮-间充质转化相关 lncRNA 特征和药物敏感性。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1154741. doi: 10.3389/fendo.2023.1154741. eCollection 2023.
5
Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.鉴定和验证六个自噬相关长非编码 RNA 作为结直肠癌的预后标志物。
Int J Med Sci. 2021 Jan 1;18(1):88-98. doi: 10.7150/ijms.49449. eCollection 2021.
6
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.用于预测胃癌总生存期的EMT相关基因特征的鉴定
Front Genet. 2021 Jun 24;12:661306. doi: 10.3389/fgene.2021.661306. eCollection 2021.
7
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.结直肠癌患者上皮-间质转化的基因组学与预后分析。
BMC Cancer. 2020 Nov 23;20(1):1135. doi: 10.1186/s12885-020-07615-5.
8
Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.N6-甲基腺嘌呤相关长链非编码RNA在早期结直肠癌中的预后价值:与免疫细胞浸润及化疗药物敏感性的关联
Front Mol Biosci. 2021 Oct 12;8:724889. doi: 10.3389/fmolb.2021.724889. eCollection 2021.
9
Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.分析唾液酸化相关长非编码 RNA 以建立新型标志物预测结直肠癌患者的预后、免疫图谱和化疗反应
Front Immunol. 2022 Oct 18;13:994874. doi: 10.3389/fimmu.2022.994874. eCollection 2022.
10
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.鉴定一种与上皮-间质转化相关的长链非编码RNA预后特征以确定肝细胞癌患者的预后和药物治疗
Front Med (Lausanne). 2022 May 24;9:850343. doi: 10.3389/fmed.2022.850343. eCollection 2022.

引用本文的文献

1
EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma.建立 EMT 相关基因风险模型预测肝细胞癌的预后和药物治疗效果。
Sci Rep. 2023 Nov 21;13(1):20380. doi: 10.1038/s41598-023-47886-z.
2
A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.中性粒细胞胞外诱捕网相关分类可预测结肠癌的预后和免疫治疗反应。
Sci Rep. 2023 Nov 7;13(1):19297. doi: 10.1038/s41598-023-45558-6.
3
Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer.

本文引用的文献

1
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.肿瘤突变负荷作为免疫治疗生物标志物面临的挑战。
Cancer Cell. 2021 Feb 8;39(2):154-173. doi: 10.1016/j.ccell.2020.10.001. Epub 2020 Oct 29.
2
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.结直肠癌中 MSI 状态与肿瘤微环境的串扰。
Front Immunol. 2020 Aug 12;11:2039. doi: 10.3389/fimmu.2020.02039. eCollection 2020.
3
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
细菌脂多糖相关基因特征可作为胃癌预后和免疫治疗的潜在生物标志物。
Sci Rep. 2023 Sep 23;13(1):15916. doi: 10.1038/s41598-023-43223-6.
4
The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients.构建新型铁死亡相关 lncRNA 模型预测结直肠癌患者预后
Medicine (Baltimore). 2023 Mar 10;102(10):e33114. doi: 10.1097/MD.0000000000033114.
5
Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.鉴定与结直肠癌上皮-间充质转化、N6-甲基腺苷修饰和免疫浸润相关的新型预后标志物。
Cancer Med. 2023 Mar;12(5):5926-5938. doi: 10.1002/cam4.5384. Epub 2022 Oct 25.
6
ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.ALKBH5 介导的 circCCDC134 的 m6A 修饰通过增强 HIF1A 转录促进宫颈癌转移。
J Exp Clin Cancer Res. 2022 Aug 26;41(1):261. doi: 10.1186/s13046-022-02462-7.
7
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.鉴定一种与上皮-间质转化相关的长链非编码RNA预后特征以确定肝细胞癌患者的预后和药物治疗
Front Med (Lausanne). 2022 May 24;9:850343. doi: 10.3389/fmed.2022.850343. eCollection 2022.
8
Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.鉴定一种新型免疫景观特征,用于预测结肠癌的预后和对免疫治疗的反应。
Front Immunol. 2022 Apr 28;13:802665. doi: 10.3389/fimmu.2022.802665. eCollection 2022.
9
General Features and Novel Gene Signatures That Identify Epstein-Barr Virus-Associated Epithelial Cancers.识别爱泼斯坦-巴尔病毒相关上皮性癌的一般特征和新型基因特征
Cancers (Basel). 2021 Dec 22;14(1):31. doi: 10.3390/cancers14010031.
深入剖析中枢神经系统淋巴瘤的肿瘤微环境,揭示免疫检查点治疗的意义。
Cancer Immunol Immunother. 2020 Sep;69(9):1751-1766. doi: 10.1007/s00262-020-02575-y. Epub 2020 Apr 25.
4
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.基于基质-肿瘤微环境的亚型的鉴定与验证,这些亚型与胃癌患者的PD-1/PD-L1免疫治疗及预后密切相关。
Cancer Cell Int. 2020 Mar 24;20:92. doi: 10.1186/s12935-020-01173-3. eCollection 2020.
5
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
6
Large-scale public data reuse to model immunotherapy response and resistance.大规模公共数据再利用以模拟免疫疗法反应和耐药性。
Genome Med. 2020 Feb 26;12(1):21. doi: 10.1186/s13073-020-0721-z.
7
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.分析肺腺癌的免疫相关特征,确定了两种不同的亚型:对免疫检查点阻断治疗的影响。
Aging (Albany NY). 2020 Feb 24;12(4):3312-3339. doi: 10.18632/aging.102814.
8
Linc00662 Promotes Tumorigenesis and Progression by Regulating miR-497-5p/AVL9 Axis in Colorectal Cancer.Linc00662通过调控miR-497-5p/AVL9轴促进结直肠癌的肿瘤发生和进展。
Front Genet. 2020 Jan 24;10:1385. doi: 10.3389/fgene.2019.01385. eCollection 2019.
9
Gene Expression-Based Identification of Antigen-Responsive CD8 T Cells on a Single-Cell Level.基于基因表达的单细胞水平鉴定抗原反应性 CD8 T 细胞。
Front Immunol. 2019 Nov 6;10:2568. doi: 10.3389/fimmu.2019.02568. eCollection 2019.
10
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?免疫疗法在转移性微卫星稳定型结直肠癌中是否有一席之地?
Front Immunol. 2019 Aug 6;10:1816. doi: 10.3389/fimmu.2019.01816. eCollection 2019.